Reuters logo
BRIEF-Akebia Therapeutics Q4 loss per share $0.99
March 6, 2017 / 9:13 PM / 6 months ago

BRIEF-Akebia Therapeutics Q4 loss per share $0.99

March 7 (Reuters) - Akebia Therapeutics Inc

* Akebia announces fourth quarter and full-year 2016 financial results

* Q4 loss per share $0.99

* Q4 earnings per share view $0.77 -- Thomson Reuters I/B/E/S

* Collaboration revenue was $1.5 million for q4 of 2016

* Akebia Therapeutics- collaboration revenue in connection with agreement with Mitsubishi Tanabe Pharma corporation is expected to commence in second half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below